Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials.

Wenyi Zhang Mingduo ZhangJinfan TianMin ZhangYuan ZhouXiantao Song

Published in: Cardiovascular therapeutics (2023)

Interventions with a DCB-only strategy are comparable to those of drug-eluting stents and superior to plain-old balloon angioplasty or bare metal stents for the treatment of selected de novo coronary lesions. Additional evidence is still warranted to confirm the value of DCB before widespread clinical utilization can be recommended.

Keyphrases

coronary artery disease
percutaneous coronary intervention
coronary artery
cardiovascular events
coronary artery bypass grafting
adverse drug
drug induced
type diabetes
emergency department
combination therapy
ejection fraction
transcatheter aortic valve replacement